Roche plans autonomous AI labs to speed drug research
A post says Roche plans to reallocate about 2 billion Swiss francs ($2.41 billion) in R&D savings to programs and productivity initiatives. It also says the company aims to bring up to 20 new molecular entities to market by 2030.
TLDR
A post says Roche outlined plans to move toward autonomous AI labs to speed research and development. It says the company plans to reallocate about 2 billion Swiss francs ($2.41 billion) in R&D savings and aims to bring up to 20 new molecular entities to market by 2030. The post attributes to Regev the figure that 40% of pipeline decisions from the fourth quarter of 2025 through the second quarter of 2026 had a tracked AI and/or computational contribution.
Combined views
82.3K
2 Sources, first seen 6h ago